Adenovirus lor neurodegenerative diseases: In vivo strategies and ex vivo gene therapy using human neural progenitors

Clinical Neuroscience

Volumn 3, Issue 5, 1995, Pages 317-321

  Sabaté, Olivier ^a   Barkats, Martine ^a   Buc Caron, Marie Hélène ^a   Castel Barthe, Marie Noëlle ^a   Finiels, Françoise ^a   Horellou, Philippe ^a   Revah, Frédéric ^a   Mallet, Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adenovirus; Gene therapy; Human neural progenitors; Neurodegenerative diseases

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEURITE PROMOTING FACTOR; SUPEROXIDE DISMUTASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN PROTECTION; EMBRYO CELL; GENE TRANSFER; HUMAN; HUMAN CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VIRUS RECOMBINANT;

ADENOVIRIDAE; GENE THERAPY; GENETIC VECTORS; HUMANS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; STEM CELL TRANSPLANTATION;

EID: 0029548609     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Akli S, Caillaud C, Vigne E, StratfordPerricaudet LD, Poenaru L, Perricaudet M, Kahn A, and Peschanski M (1993): Transfer of a foreign gene into the brain using adenövirus vectors. Nature Genet 3:224-228.
2. Anton R, Kordower JH, Maidment NT, Manaster JS, Kane DJ, Rabizadeh S, Schueller SB, Yang J, Rabizadeh S, Edwards RH, Markham CH, Bredesen DE (1994): Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 127:207-218.
3. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A (1993): Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenövirus vectors. Nature Genet 3:229-234.
4. Barkats M, Bemelmans A, Geoffroy MC, Robert JJ, Loquet I, Horellou P, Revah F, Mallet J (1996): An adenövirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. Neuroreport 7:497-501.
5. Bensimon G, Lacomblez L, Meininger V (1994): A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585-591.
6. Brown RH (1995): Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell 80:687-692.
7. Buc-Caron M-H (1995): Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol Dis 2:37-47.
8. Byrnes AP, Rusby JE, Wood MJ, Charlton HM (1995): Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024.
9. Byrnes AP, MacLaren RE, Charlton HM (1996): Immunological instability of persistent adenövirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci 16:3045-3055.
10. Castel-Barthe MN, Jazat-Poindessous F, Barneoud P, Vigne E, Revah F, Mallet J, Lamour Y (1996): Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: Effect on basal forebrain cholinergic neurons during aging. Neurobiol Dis 1:67-78.
11. Coyle JT, Puttfarcken P (1993): Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689-695.
12. Davidson BL, Alien ED, Kozarsky KF, Wilson JM, Roessler BJ (1993): A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 3:219-223.
13. During MJ, Naegele JR, O'Malley KL, Geller AI (1994): Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403.
14. Engelhardt JF, Ye X, Doranz B, Wilson JM (1994): Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91:6196-6200.
15. Finch CE (1993): Neuron atrophy during aging: Programmed or sporadic? Trends Neurosci 16:104-110.
16. Finiels F, Gimenez-Ribotta M, Barkats M, Samolyk ML, Robert JJ, Privât A, Revah F, Mallet J (1995): Specific and efficient gene transfer strategy for the treatment of motor neurone diseases. Neuroreport 6:2473-2478.
17. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM (1996): Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11-22.
18. Fisher LJ, Jinnah HA, Kale LC, Higgins GA, Gage FH (1991): Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron 6:371-380.
19. Fisher W, Björklund A, Chen K, Gage FH (1991): NGF improves spatial memory in aged rats as a function of age. J Neurosci 11:1889-1906.
20. Horellou P, Sinden P, Kaien P, Mallet J, Björklund A (1990): In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393-402.
21. Horellou P, Vigne E, Castel MN, Barnéoud P, Colin P, Perricaudet M, Delaère P, Mallet J (1994): Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport 6:49-53.
22. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994): Long-term gene expression and phenotypic correction using adenoassociated virus vectors in the mammalian brain. Nature Genet 8:148-154.
23. Längsten JW, Ballard P, Tetrud JW, Irwin I (1983): Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 219:979-980.
24. Le Gai La Salle G, Robert J-J, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993): An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
25. Levallois C, Privat A, Mallet J (1994): Adenovirus insertion encoding the Lac Z gene in human nervous cells in primary dissociated cultures. CR Acad Sci Paris, Life Sciences 317:495-498.
26. Lindsay RM (1995): Neuron saving schemes. Nature 373:289-290.
27. Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D, Sinden P, Frackowiak R, Marsden CD, Odin P, Rehncrone SH (1994). Evidence for longterm survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:172-180.
28. Lundberg C, Horellou P, Mallet J, Björklund A (1996): Generation of DOPAproducing astrocy tes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characteriza-tion and in vivo effects in the rat Parkinson model. Exp Neurol 139:39-53.
29. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
30. Revah F, Horellou P, Vigne E, Le Gal la Salle G, Robert JJ, Perricaudet M, Mallet J (1996): Gene therapy of degenerative and genetic disorders of the central and peripheral nervous system using adenoviral vectors. In Lowenstein P, Enquist L (eds): Gene transfer into neuronesTowards gene therapy of neurological disorders. Chichester: John Wiley & Sons, pp 81-92.
31. Ridoux V, Robert JJ, Zhang X, Perricaudet M, Mallet J, Le Gai La Salle G (1994a): The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. NeuroReport 5:801-804.
32. Ridoux V, Robert JJ, Zhang X, Perricaudet M, Mallet J, Le Gai La Salle G (1994b): Adenoviral vectors as functional retrograde neuronal tracers. Brain Res 648: 171-175.
33. Roses AD (1996): From genes to mechanisms to therapies: Lessons to be learned from neurological disorders. Nature Med 2:267-269.
34. Rubin BA, Rorke LB (1988): Adenovirus vaccines. In Plotkin SA, Mortimer EA (eds): Vaccines. Philadelphia: WB Saunders, pp 492-512.
35. Sabaté O, Horellou P, Vigne E, Colin P, Perricaudet M, Buc-Caron M-H, Mallet J (1995): Transplantation to the rat brain of human neural progenitors which were genetically modified using adenoviruses. Nature Genet 9:256-260.
36. Sinden JD, Patel SN, Hodges H (1992): Neural transplantation: Problems and prospects for therapeutic applications. Cur Opin Neurol Neurosurg 5:902-908.
37. Tuszynski MH, Gage FH (1994): Neurotrophic factors and diseases of the nervous system. Ann Neurol 35:S5-S12.
38. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ (1995): Essential role of neocortical acetylcholine in spatial memory. Nature 375:484-487.
39. Yankner BA (1996): Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932.
40. Yang Y, Nunes FA, Berensci K, Gönczöl E, Englehardt JF, Wilson JM (1994): Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet 7:362-369.
41. Yeh P, Dedieu JF, Orsini C, Vigne E, Denefle P, Perricaudet M (1996): Efficient dual transcomplementation of adenovirus El and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 70:559565.
42. Yoshimoto Y, Lin Q, Collier TJ, Frim DM, Breakefield XO, Bohn MC (1995): Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res 691:25-36.